EDIT
Price
$5.22
Change
-$0.13 (-2.43%)
Updated
Apr 25, 6:59 PM EST
5 days until earnings call
VIR
Price
$7.63
Change
-$0.41 (-5.10%)
Updated
Apr 25, 6:59 PM EST
6 days until earnings call
Ad is loading...

EDIT vs VIR ᐉ Comparison: Which is Better to Invest?

Header iconEDIT vs VIR Comparison
Open Charts EDIT vs VIRBanner chart's image
Editas Medicine
Price$5.22
Change-$0.13 (-2.43%)
Volume$927.69K
CapitalizationN/A
Vir Biotechnology
Price$7.63
Change-$0.41 (-5.10%)
Volume$531.96K
CapitalizationN/A
View a ticker or compare two or three
EDIT vs VIR Comparison Chart

Loading...

EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
EDIT vs. VIR commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and VIR is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (EDIT: $5.22 vs. VIR: $7.63)
Brand notoriety: EDIT and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 77% vs. VIR: 94%
Market capitalization -- EDIT: $429.27M vs. VIR: $1.04B
EDIT [@Biotechnology] is valued at $429.27M. VIR’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $562.44B to $0. The average market capitalization across the [@Biotechnology] industry is $2.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, VIR is a better buy in the long-term than EDIT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 2 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 2 bullish, 3 bearish.
  • VIR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VIR is a better buy in the short-term than EDIT.

Price Growth

EDIT (@Biotechnology) experienced а -5.95% price change this week, while VIR (@Biotechnology) price change was -4.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.76%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +1257.31%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 31, 2024.

VIR is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for EDIT with price predictions.
OPEN
A.I.dvisor published
a Summary for VIR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VIR($1.04B) has a higher market cap than EDIT($429M). VIR YTD gains are higher at: -20.080 vs. EDIT (-48.470).
EDITVIREDIT / VIR
Capitalization429M1.04B41%
EBITDAN/AN/A-
Gain YTD-48.470-20.080241%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITVIR
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
EDITDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISGOX13.76N/A
N/A
Columbia Integrated Small Cap Gr Ins 2
FQITX12.43-0.02
-0.16%
Fidelity SAI International Qly Idx
CMEUX17.91-0.03
-0.17%
Six Circles Mgd Eq Port US Uncons
ACAYX38.84-0.13
-0.33%
Alger Capital Appreciation Instl Y
AVDNX11.83-0.04
-0.34%
Avantis® International Equity G

EDIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDIT has been closely correlated with NTLA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if EDIT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDIT
1D Price
Change %
EDIT100%
-2.43%
NTLA - EDIT
68%
Closely correlated
-5.43%
BEAM - EDIT
63%
Loosely correlated
-5.01%
AXON - EDIT
52%
Loosely correlated
+1.27%
VCYT - EDIT
49%
Loosely correlated
-2.11%
ALLO - EDIT
48%
Loosely correlated
-6.09%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-1.11%
AXON - VIR
47%
Loosely correlated
+0.28%
GOSS - VIR
44%
Loosely correlated
-3.97%
MORF - VIR
38%
Loosely correlated
-3.69%
VRDN - VIR
37%
Loosely correlated
-8.56%
MDGL - VIR
36%
Loosely correlated
-6.29%
More